150 related articles for article (PubMed ID: 38232994)
1. National Volume-Based Procurement (NVBP) exclusively for insulin: towards affordable access in China and beyond.
Yuan J; Li M; Jiang X; Lu ZK
BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232994
[TBL] [Abstract][Full Text] [Related]
2. Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China.
Yuan J; Lu ZK; Xiong X; Jiang B
BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34518200
[TBL] [Abstract][Full Text] [Related]
3. Improving access to medicines and beyond: the national volume-based procurement policy in China.
Zhu Z; Wang Q; Sun Q; Lexchin J; Yang L
BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37463786
[TBL] [Abstract][Full Text] [Related]
4. Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin.
Zhao B; Wu J
Int J Health Policy Manag; 2023; 12():7724. PubMed ID: 38618801
[TBL] [Abstract][Full Text] [Related]
5. Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus.
Yuan J; Lu ZK; Xiong X; Lee TY; Huang H; Jiang B
Front Pharmacol; 2022; 13():842944. PubMed ID: 35734415
[No Abstract] [Full Text] [Related]
6. The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian's structure-process-outcome framework.
Wang Q; Liu S; Nie Z; Zhu Z; Fu Y; Zhang J; Wei X; Yang L; Wei X
J Glob Health; 2023 Nov; 13():04137. PubMed ID: 37947028
[TBL] [Abstract][Full Text] [Related]
7. Patients' attitudes towards switching to national volume-based procurement (NVBP) Drugs-a qualitative investigation in Wuhan, China.
Tao J; Li S; Xu Q; Gong S; Zeng F
BMC Health Serv Res; 2023 Jan; 23(1):62. PubMed ID: 36670463
[TBL] [Abstract][Full Text] [Related]
8. Effects of volume-based procurement policy on the usage and expenditure of first-generation targeted drugs for non-small cell lung cancer with EGFR mutation in China: an interrupted time series study.
Wang X; Huang H; Sun Y; Zhu Z; Jiang B; Yang L
BMJ Open; 2023 Jul; 13(7):e064199. PubMed ID: 37407064
[TBL] [Abstract][Full Text] [Related]
9. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
10. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China.
Liu C; Zhang X; Liu C; Ewen M; Zhang Z; Liu G
BMC Health Serv Res; 2017 Aug; 17(1):597. PubMed ID: 28836974
[TBL] [Abstract][Full Text] [Related]
11. Availability, affordability and price components of insulin products in different-level hospital pharmacies: Evidence from two cross-sectional surveys in Nanjing, China.
Wang L; Dai L; Liu H; Dai H; Li X; Ge W
PLoS One; 2021; 16(8):e0255742. PubMed ID: 34383816
[TBL] [Abstract][Full Text] [Related]
12. Insulin prices, availability and affordability in 13 low-income and middle-income countries.
Ewen M; Joosse HJ; Beran D; Laing R
BMJ Glob Health; 2019; 4(3):e001410. PubMed ID: 31263585
[TBL] [Abstract][Full Text] [Related]
13. The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China.
Zhang Y; Wushouer H; Han S; Fu M; Guan X; Shi L; Wagner A
BMJ Glob Health; 2021 Jul; 6(7):. PubMed ID: 34266848
[TBL] [Abstract][Full Text] [Related]
14. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
Todesco B; Ostuzzi G; Barbui C
Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
[TBL] [Abstract][Full Text] [Related]
15. The impact of Chinese volume-based procurement on pharmaceutical market concentration.
Yang Y; Liu Y; Mao Z; Mao J; Jin Y
Front Pharmacol; 2024; 15():1386533. PubMed ID: 38895618
[TBL] [Abstract][Full Text] [Related]
16. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico.
Moye-Holz D; van Dijk JP; Reijneveld SA; Hogerzeil HV
Value Health Reg Issues; 2019 Dec; 20():129-135. PubMed ID: 31374426
[TBL] [Abstract][Full Text] [Related]
18. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices.
Beran D; Laing RO; Kaplan W; Knox R; Sharma A; Wirtz VJ; Frye J; Ewen M
Diabet Med; 2019 Jun; 36(6):726-733. PubMed ID: 30888075
[TBL] [Abstract][Full Text] [Related]
19. Prices, availability and affordability of medicines in Rwanda.
Bizimana T; Kayumba PC; Heide L
PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
[TBL] [Abstract][Full Text] [Related]
20. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]